Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer

被引:43
作者
Holmberg, E
Rozell, BL
Toftgard, R
机构
[1] KAROLINSKA INST,NOVUM,DEPT BIOSCI,S-14157 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,NOVUM,CTR NUTR & TOXICOL,S-14157 HUDDINGE,SWEDEN
[3] HUDDINGE UNIV HOSP,DEPT PATHOL,S-14186 HUDDINGE,SWEDEN
关键词
chromosome; 9q; basal cell carcinoma; squamous fell carcinoma; naevoid basal cell carcinoma syndrome; loss of heterozygosity; microsatellite marker;
D O I
10.1038/bjc.1996.345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Familial predisposition to basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin are apparent in the autosomal dominant syndromes naevoid basal cell carcinoma syndrome (NBCCS) and multiple self-healing squamous epitheliomata (MSSE) respectively. The gene responsible for NBCCS has been proposed to be a tumour-suppressor gene and is mapped to the same 2 Mb interval on 9q22.3 as the MSSE gene ESS1. In an attempt to further map the NBCCS gene, we have examined loss of heterozygosity (LOH) in 16 sporadic BCCs and two familial BCCs using microsatellite markers located within the candidate gene region. The overall frequency of LOH observed was 67% in the BCCs and partial or interstitial deletions were found in eight tumours, with the highest LOH frequency at markers D9S280. D9S287 and D9S180. To determine if the same genomic region also shows frequency LOH in tumours with a squamous phenotype, we have examined 11 SCCs, four actinic keratoses and 13 cases of Bowen's disease for LOH at 9q22.3. An overall LOH frequency of 50% was observed at D9S180, and occurred in all types of squamous tumours. In contrast, a much lower LOH frequency of only 6% was found at the D9SZ87 locus. Our observation of different patterns of LOH at 9q22.3 in sporadic BCCs and SCCs implies that more than one tumour-suppressor gene might be located in this genomic region.
引用
收藏
页码:246 / 250
页数:5
相关论文
共 39 条
[1]  
AHSEE KW, 1994, CANCER RES, V54, P1617
[2]  
BARE JW, 1995, J INVEST DERMATOL, V104, P604
[3]   PARENTAL ORIGIN OF CHROMOSOME 9Q22.3-Q31 LOST IN BASAL-CELL CARCINOMAS FROM BASAL-CELL NEVUS SYNDROME PATIENTS [J].
BONIFAS, JM ;
BARE, JW ;
KERSCHMANN, RL ;
MASTER, SP ;
EPSTEIN, EH .
HUMAN MOLECULAR GENETICS, 1994, 3 (03) :447-448
[4]   A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA [J].
BRASH, DE ;
RUDOLPH, JA ;
SIMON, JA ;
LIN, A ;
MCKENNA, GJ ;
BADEN, HP ;
HALPERIN, AJ ;
PONTEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10124-10128
[5]   RAPID DETECTION OF ALLELE LOSS IN COLORECTAL TUMORS USING MICROSATELLITES AND FLUORESCENT DNA TECHNOLOGY [J].
CAWKWELL, L ;
BELL, SM ;
LEWIS, FA ;
DIXON, MF ;
TAYLOR, GR ;
QUIRKE, P .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1262-1267
[6]  
CHENEVIXTRENCH G, 1993, AM J HUM GENET, V53, P760
[7]   COMPLICATIONS OF THE NEVOID BASAL-CELL CARCINOMA SYNDROME - RESULTS OF A POPULATION-BASED STUDY [J].
EVANS, DGR ;
LADUSANS, EJ ;
RIMMER, S ;
BURNELL, LD ;
THAKKER, N ;
FARNDON, PA .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (06) :460-464
[8]   LOCATION OF GENE FOR GORLIN SYNDROME [J].
FARNDON, PA ;
DELMASTRO, RG ;
EVANS, DGR ;
KILPATRICK, MW .
LANCET, 1992, 339 (8793) :581-582
[9]   ANALYSIS OF 133 MEIOSES PLACES THE GENES FOR NEVOID BASAL-CELL CARCINOMA (GORLIN)-SYNDROME AND FANCONI-ANEMIA GROUP-C IN A 2.6-CM INTERVAL AND CONTRIBUTES TO THE FINE MAP OF 9Q22.3 [J].
FARNDON, PA ;
MORRIS, DJ ;
HARDY, C ;
MCCONVILLE, CM ;
WEISSENBACH, J ;
KILPATRICK, MW ;
REIS, A .
GENOMICS, 1994, 23 (02) :486-489
[10]   DEVELOPMENTAL DEFECTS IN GORLIN SYNDROME RELATED TO A PUTATIVE TUMOR SUPPRESSOR GENE ON CHROMOSOME-9 [J].
GAILANI, MR ;
BALE, SJ ;
LEFFELL, DJ ;
DIGIOVANNA, JJ ;
PECK, GL ;
POLIAK, S ;
DRUM, MA ;
PASTAKIA, B ;
MCBRIDE, OW ;
KASE, R ;
GREENE, M ;
MULVIHILL, JJ ;
BALE, AE .
CELL, 1992, 69 (01) :111-117